methylprednisolone hemisuccinate and Immunoblastic Large-Cell Lymphoma

methylprednisolone hemisuccinate has been researched along with Immunoblastic Large-Cell Lymphoma in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (50.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cabanillas, F; Dong, K; Hagemeister, FB; McLaughlin, P; Moon, T; Rodriguez, MA; Rodriguez-Diaz Pavón, J; Romaguera, JE	1
Cabanillas, FF; Cox, JD; Ha, CS; Hess, MA; Rodriguez, MA; Tucker, SL; Wilder, RB	1

Trials

2 trial(s) available for methylprednisolone hemisuccinate and Immunoblastic Large-Cell Lymphoma

Article	Year
Alternating triple therapy for the treatment of intermediate grade and immunoblastic lymphoma. Annals of oncology : official journal of the European Society for Medical Oncology, 1998, Volume: 9, Issue:5 Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Cyclophosphamide; Cytarabine; Dexamethasone; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Lymphoma, Large-Cell, Immunoblastic; Lymphoma, Non-Hodgkin; Male; Mesna; Methotrexate; Methylprednisolone Hemisuccinate; Middle Aged; Mitoxantrone; Prednisone; Prognosis; Vincristine	1998
Radiation therapy after a partial response to CHOP chemotherapy for aggressive lymphomas. International journal of radiation oncology, biology, physics, 2001, Jul-01, Volume: 50, Issue:3 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Disease-Free Survival; Doxorubicin; Etoposide; Humans; Ifosfamide; Lymphoma, Large-Cell, Immunoblastic; Lymphoma, Non-Hodgkin; Mesna; Methylprednisolone Hemisuccinate; Middle Aged; Mitoxantrone; Prednisone; Retrospective Studies; Salvage Therapy; Vincristine	2001

Article

Year

Alternating triple therapy for the treatment of intermediate grade and immunoblastic lymphoma.

Annals of oncology : official journal of the European Society for Medical Oncology, 1998, Volume: 9, Issue:5

Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Cyclophosphamide; Cytarabine; Dexamethasone; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Lymphoma, Large-Cell, Immunoblastic; Lymphoma, Non-Hodgkin; Male; Mesna; Methotrexate; Methylprednisolone Hemisuccinate; Middle Aged; Mitoxantrone; Prednisone; Prognosis; Vincristine

1998

Radiation therapy after a partial response to CHOP chemotherapy for aggressive lymphomas.

International journal of radiation oncology, biology, physics, 2001, Jul-01, Volume: 50, Issue:3

Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Disease-Free Survival; Doxorubicin; Etoposide; Humans; Ifosfamide; Lymphoma, Large-Cell, Immunoblastic; Lymphoma, Non-Hodgkin; Mesna; Methylprednisolone Hemisuccinate; Middle Aged; Mitoxantrone; Prednisone; Retrospective Studies; Salvage Therapy; Vincristine

2001